Terns Pharmaceuticals Inc

TERN

Latest QuantConomy context for TERN: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class

stock

Primary venue

NASDAQ

Recent signals

SEC filings

Asset profile

QuantConomy has a structured record for TERN. More descriptive asset metadata will appear here when the platform record includes it.

Latest signal rows

Recent signals for TERN

Scored rows are pulled from the same signal API used by the digests.

Signal	Direction	Score	Observed	Reason
earnings earnings release	neutral	40	Jan 9, 12:00 AM	TERN filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-01-09. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read).
corporate event acquisition disposition	very bearish	100	May 5, 01:25 PM	TERN filed 8-K: Acquisition or Disposition, Delisting Notice, Modification to Rights of Security Holders - 6 material events - [very strong very bearish signal]
corporate event reg fd disclosure	neutral	80	Apr 27, 12:15 PM	TERN filed 8-K: Regulation FD Disclosure, Other Events - 2 material events - [very strong neutral signal]

EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).

Market	Exchange	Source	Asset record
TERN	NASDAQ	alphavantage	Terns Pharmaceuticals Inc
TERN	NASDAQ	alpaca	Terns Pharmaceuticals, Inc. Common Stock
TERN	NASDAQ	fmp	Terns Pharmaceuticals, Inc.

Buys, last 90d

Sells, last 90d

Rows

No recent Form 3, 4, or 5 insider transaction rows were returned for TERN.

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.